FOXM1 promotes the progression of non-small cell lung cancer by inhibiting miR-509-5p expression via binding to the miR-509-5p promoter region.

Heliyon · 2024 · PMC10943339 · PMID 38495135

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, the migration rate of A549 cells showed an increasing trend after co-treatment with FDI-6 and miR-509-5p inhibitor ( Fig. 3 a and b ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.